Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2737]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Pembrolizumab for head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab for head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Nivolumab extends survival for patients with the most common lung cancer
Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Nivolumab extends survival for patients with the most common lung cancer ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
29 May 2015
Pembrolizumab shows promising activity against head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab shows promising activity against head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Prostate cancer and pharmacokinetics: Expert discussion
Prof Axel S. Merseburger and Prof Romano Danesi
Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )
26 May 2015
Latest developments in prostate cancer
Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter...
Latest developments in prostate cancer ( Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter Iversen )
20 May 2015
New approaches to diffuse large B-cell lymphoma
Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust...
New approaches to diffuse large B-cell lymphoma ( Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust, Southampton, UK )
6 May 2015
Comment: Metastatic triple-negative breast cancer responds to immunotherapy
Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA
Comment: Metastatic triple-negative breast cancer responds to immunotherapy ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )
1 May 2015
Real-world targeted treatment based on whole genome sequencing difficult in...
Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst...
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer ( Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia )
1 May 2015
Investigational PD-L1–targeted immunotherapy safe for patients with triple...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
1 May 2015
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 May 2015
New data shows that generic drivers are found in benign conditions
Prof Razelle Kurzrock - University of California, San Diego, USA
New data shows that generic drivers are found in benign conditions ( Prof Razelle Kurzrock - University of California, San Diego, USA )
30 Apr 2015
ecancermedicalscience editor's choice for April 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for April 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
30 Apr 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation